Advertisement

Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Document › Details

Nynomic AG. (11/13/20). "Press Release: Capital Increase Fully Placed". Wedel.

Organisation Organisation Nynomic (Group)
Products Product optical instruments
  Product 2 photonics
     


Nynomic AG (WKN: A0MSN1, ISIN: DE000A0MSN11) has successfully completed its capital increase, as resolved yesterday, from EUR 5,438,500.00 by up to EUR 253,500.00 to up to EUR 5,692,000.00 by issuing up to 253,500 new no-par value bearer shares against cash contributions, making partial use of the existing “Authorized Capital 2019” and excluding the subscription rights of shareholders. The capital increase was significantly oversubscribed. The 253,500 new shares were successfully placed with institutional investors by means of an accelerated bookbuilding process at a placement price of EUR 28.00 per new share. Subject to the registration of the capital increase in the commercial register, the gross proceeds from the capital increase are EUR 7,098,000.00. After completion of the capital increase, the Company’s share capital amounts to EUR 5,692,000.00. Registration of the implementation of the capital increase in the commercial register is expected shortly.


About Nynomic:

Nynomic AG is an internationally leading manufacturer of products for permanent, non-contact and non-destructive optical measurement technology. The products and services of the Nynomic Group are based on a wide range of intelligent sensors for measuring optical radiation and smart technologies for data acquisition, processing and evaluation. They can be scaled into different application areas and represent high efficiency increase and high customer benefit due to their good adaptability to customer processes. Miniaturization, digitization, automation – Nynomic consistently uses the constant technological change as the basis for above-average growth in the medium term compared to the market. The Nynomic Group has a clear marketing concept as a full-service provider from component to solution. It is globally positioned with independent brands and subsidiaries and around 425 employees.

This is a translation of the original German ad hoc announcement/ corporate press release. Only the original German ad hoc announcement/ corporate press release is binding. No liability is accepted for the correctness of the translation.

More information on the company is available on the corporate website at www.nynomic.com/en.


Nynomic AG
Am Marienhof 2
22880 Wedel
Germany
www.nynomic.com

For further inquiries:
Jochen Fischer
FISCHER RELATIONS
Neuer Wall 50
D – 20354 Hamburg
phone: + 49(0)40 822 186 380
fax: + 49(0)40 822 186 450
info@fischer-relations.de

   
Record changed: 2020-12-23

Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81




» top